Company intelligence / Profile preview

Rocky Mountain

Pueblo, Colorado, United States

Ownership: Private
Development stage: Other

Overview

Rocky Mountain Biotech is a private Colorado biotechnology company focused on biopharmaceutical cannabis research and development. The company is pursuing federally compliant cannabis manufacturing and research capabilities to support scientific investigation of plant-based therapeutics. Its stated goal is to develop an FDA-approved cannabis-derived formulation, with pain management described as an initial focus area. Available public information suggests the company remains at an early stage, centered on preclinical research, regulatory enablement, and quality systems such as GLP, GMP, and GAP-oriented operations.

Therapeutic areas: Neurology
Modalities: Small molecule
Industry: Biotech

Partnerships

Colorado State University Pueblo

Beyond the preview

Go deeper on Rocky Mountain.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rocky Mountain.

Explore the full profile